On 12th December, Wuhan University Hoyo Co., Ltd. announce its Carbocisteine will be exported to South Korea as a drug not as a chemical product. This is the first time that Chinese amino acid API can be directly sold to the finished drug manufactures in South Korea.
There is a mutual recognition agreement between South Korea Drug Regulatory Authority, USA FDA and Europe Union, so University Hoyo's Carbocisteine expects to pass COS Authentication. Now University Hoyo plans to invest 3 million Yuan on the initiation of COS Authentication.